Cargando…

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD

Neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are increasing in prevalence but lack targeted therapeutics. Although the pathological mechanisms behind these diseases remain unclear, both ALS and FTD are characterized pathologically by aberr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hedl, Thomas J., San Gil, Rebecca, Cheng, Flora, Rayner, Stephanie L., Davidson, Jennilee M., De Luca, Alana, Villalva, Maria D., Ecroyd, Heath, Walker, Adam K., Lee, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579929/ https://www.ncbi.nlm.nih.gov/pubmed/31244593 http://dx.doi.org/10.3389/fnins.2019.00548

Ejemplares similares

Unbiased Label-Free Quantitative Proteomics of Cells Expressing Amyotrophic Lateral Sclerosis (ALS) Mutations in CCNF Reveals Activation of the Apoptosis Pathway: A Workflow to Screen Pathogenic Gene Mutations
por: Cheng, Flora, et al.
Publicado: (2021)

Inter-Regional Proteomic Profiling of the Human Brain Using an Optimized Protein Extraction Method from Formalin-Fixed Tissue to Identify Signaling Pathways
por: Davidson, Jennilee M., et al.
Publicado: (2023)

The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis
por: Davidson, Jennilee M., et al.
Publicado: (2023)

Examining the language and behavioural profile in FTD and ALS-FTD
por: Saxon, Jennifer A, et al.
Publicado: (2017)

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics
por: Vignaroli, Francesca, et al.
Publicado: (2023)

Using bicistronic constructs to evaluate the chaperone activities of heat shock proteins in cells
por: San Gil, Rebecca, et al.
Publicado: (2017)

Inflammation in ALS/FTD pathogenesis
por: McCauley, Madelyn E., et al.
Publicado: (2018)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

Motor Neuron Susceptibility in ALS/FTD
por: Ragagnin, Audrey M. G., et al.
Publicado: (2019)

Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD
por: Luan, Wei, et al.
Publicado: (2023)

Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
por: Godoy-Corchuelo, Juan Miguel, et al.
Publicado: (2022)

The heat shock response in neurons and astroglia and its role in neurodegenerative diseases
por: San Gil, Rebecca, et al.
Publicado: (2017)

The era of cryptic exons: implications for ALS-FTD
por: Mehta, Puja R., et al.
Publicado: (2023)

Regional Differences in Heat Shock Protein 25 Expression in Brain and Spinal Cord Astrocytes of Wild-Type and SOD1 (G93A) Mice
por: San Gil, Rebecca, et al.
Publicado: (2021)

Cognitive and behavioral features of c9FTD/ALS
por: Boeve, Bradley F, et al.
Publicado: (2012)

Linking hnRNP Function to ALS and FTD Pathology
por: Purice, Maria D., et al.
Publicado: (2018)

ALS/FTD: Evolution, Aging, and Cellular Metabolic Exhaustion
por: Henderson, Robert David, et al.
Publicado: (2022)

Neural circuit and synaptic dysfunctions in ALS-FTD pathology
por: Mora, Santiago, et al.
Publicado: (2023)

Variably protease‐sensitive prionopathy presenting within ALS/FTD spectrum
por: Vicente‐Pascual, Mikel, et al.
Publicado: (2018)

Plasma proteome profiling identifies changes associated to AD but not to FTD
por: Mofrad, R. Babapour, et al.
Publicado: (2022)

Clinical and neuropathological features of ALS/FTD with TIA1 mutations
por: Hirsch-Reinshagen, Veronica, et al.
Publicado: (2017)

Moving Toward Patient-Tailored Treatment in ALS and FTD: The Potential of Genomic Assessment as a Tool for Biological Discovery and Trial Recruitment
por: Broce, Iris J., et al.
Publicado: (2021)

Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum
por: Steketee, Rebecca M.E., et al.
Publicado: (2016)

ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation
por: Ragagnin, Audrey M. G., et al.
Publicado: (2023)

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain
por: Umoh, Mfon E, et al.
Publicado: (2017)

Neuroanatomical Quantitative Proteomics Reveals Common Pathogenic Biological Routes between Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Iridoy, Marina Oaia, et al.
Publicado: (2018)

Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci
por: He, Fang, et al.
Publicado: (2016)

Pathogenesis of FUS-associated ALS and FTD: insights from rodent models
por: Nolan, Matthew, et al.
Publicado: (2016)

From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline
por: Liscic, Rajka Maria, et al.
Publicado: (2020)

Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS‐FTD spectrum
por: Devenney, Emma M., et al.
Publicado: (2021)

Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
por: De Marchi, Fabiola, et al.
Publicado: (2023)

The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum
por: Vinceti, Giulia, et al.
Publicado: (2023)

Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Poor communication between ER and mitochondria: a signature of ALS/FTD?
por: Miller, Christopher C.J., et al.
Publicado: (2023)

Coexistence of perseveration and apathy in the TDP-43(Q331K) knock-in mouse model of ALS–FTD
por: Kim, Eosu, et al.
Publicado: (2020)

Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum
por: Bartoletti-Stella, Anna, et al.
Publicado: (2021)

Editorial: Cognitive and Behavioral Features in ALS: Beyond Motor Impairment in ALS-FTD Spectrum Disorders
por: Bersano, Enrica, et al.
Publicado: (2022)

Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Yunusova, Yana, et al.
Publicado: (2016)

The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD
por: Freibaum, Brian D., et al.
Publicado: (2017)

Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium
por: Limanaqi, Fiona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mcedb671af9gcm6ped68q1sqih